Skip to search formSkip to main contentSkip to account menu

nebacumab

Known as: HA-1A monoclonal antibody, septomonab 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

Centoxin

Broader (1)

Monoclonal Antibodies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Antiendotoxin Monoclonal Antibodies in Sepsis
Gram-negative bacteria release lipopolysaccharide (endotoxin) that causes sepsis and septic shock. Monoclonal antibodies against… 
Review
1994
Review
1994
Teaching the Tools of Pharmaceutical Care Decision-Analysis
Review
1994
Review
1994
Sepsis management and antiendotoxin therapy after nebacumab. A reappraisal.
1993
1993
Single-dose pharmacokinetics and safety of HA-1A, a human IgM anti-lipid-A monoclonal antibody, in pediatric patients with sepsis syndrome.
1992
1992
P & T Committee response to evolving technologies: preparing for the launch of high-tech, high-cost products. Roundtable discussion.
P & T Committees are entering an exciting era in which the introduction of biotechnology-derived pharmaceuticals is providing… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)